Save your place

Sign in to WhoBought

Please try again later.

Jim Simons's Akebia Therapeutics, Inc. (AKBA) position

Yes: as of Q1 2026, Jim Simons holds 1.8M shares of AKBA worth $2.5M (0.0% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$2.5M
Shares held
1.8M
% of portfolio
0.0%
Est. average buy price (i)
$2.09
est. since Q4 2025
Quarter-end price
$1.39

Estimated trade prices

Average price in quarters with purchases
$1.18
Average prices in quarters with sales
  • Q1 2026: $1.37 (1.8M shares sold)
  • Q3 2025: $3.33 (242K shares sold)
  • Q3 2024: $1.34 (197K shares sold)
  • Q1 2024: $1.60 (1.1M shares sold)
  • Q3 2023: $1.28 (175K shares sold)
  • Q4 2022: $0.31 (130K shares sold)
  • Q4 2021: $2.73 (327K shares sold)
  • Q3 2021: $2.86 (878K shares sold)

AKBA price vs Simons's position

1Y 3Y 5Y MAX
Dates
$0.2$2$420222023202420252026Sold 878K shares (48.0%) · Q3 2021. Average closing price $2.86 · Price range $2.35–$3.88878KsharessoldSold 327K shares (34.4%) · Q4 2021. Average closing price $2.73 · Price range $2.26–$3.34327KsharessoldAdded 479K shares (47.7%) · Q2 2022. Average closing price $0.42 · Price range $0.32–$0.67479KsharespurchasedAdded 1.5M shares (103.5%) · Q3 2022. Average closing price $0.39 · Price range $0.30–$0.461.5MsharespurchasedSold 130K shares (4.3%) · Q4 2022. Average closing price $0.31 · Price range $0.25–$0.58130KsharessoldAdded 992K shares (42.4%) · Q2 2023. Average closing price $0.97 · Price range $0.51–$1.43992KsharespurchasedSold 175K shares (5.3%) · Q3 2023. Average closing price $1.28 · Price range $0.87–$1.84175KsharessoldAdded 1.6M shares (51.5%) · Q4 2023. Average closing price $1.02 · Price range $0.80–$1.281.6MsharespurchasedSold 1.1M shares (23.6%) · Q1 2024. Average closing price $1.60 · Price range $1.27–$2.241.1MsharessoldAdded 263K shares (7.2%) · Q2 2024. Average closing price $1.24 · Price range $0.86–$1.63263KsharespurchasedSold 197K shares (5.0%) · Q3 2024. Average closing price $1.34 · Price range $0.94–$1.55197KsharessoldAdded 106K shares (2.8%) · Q4 2024. Average closing price $1.74 · Price range $1.28–$2.13106KsharespurchasedAdded 189K shares (4.7%) · Q2 2025. Average closing price $2.75 · Price range $1.55–$3.97189KsharespurchasedSold 242K shares (5.8%) · Q3 2025. Average closing price $3.33 · Price range $2.71–$4.01242KsharessoldSold 1.8M shares (49.0%) · Q1 2026. Average closing price $1.37 · Price range $1.18–$1.551.8Msharessold← Earlier —1 purchase
Average closing price · filing quarter
$1.37
Price range · filing quarter
$1.18 – $1.55
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −1.8M −$2.4M −49.0% 1.8M May 14, 2026
Q4 2025 First covered – – – 3.6M Feb 12, 2026
Q3 2025 Reduced −242K −$804K −5.8% 4.0M Nov 13, 2025
Q2 2025 Added +189K +$518K +4.7% 4.2M Aug 13, 2025
Q1 2025 First covered – – – 4.0M May 14, 2025
Q4 2024 Added +106K +$184K +2.8% 3.8M Feb 13, 2025
Q3 2024 Reduced −197K −$263K −5.0% 3.7M Nov 13, 2024
Q2 2024 Added +263K +$325K +7.2% 3.9M Aug 9, 2024
Q1 2024 Reduced −1.1M −$1.8M −23.6% 3.7M May 13, 2024
Q4 2023 Added +1.6M +$1.7M +51.5% 4.8M Feb 13, 2024
Q3 2023 Reduced −175K −$225K −5.3% 3.2M Nov 14, 2023
Q2 2023 Added +992K +$958K +42.4% 3.3M Aug 11, 2023
Q1 2023 First covered – – – 2.3M May 12, 2023
Q4 2022 Reduced −130K −$41K −4.3% 2.9M Feb 13, 2023
Q3 2022 Added +1.5M +$602K +103.5% 3.0M Nov 14, 2022
Q2 2022 Added +479K +$201K +47.7% 1.5M Aug 12, 2022
Q1 2022 First covered – – – 1.0M May 13, 2022
Q4 2021 Reduced −327K −$891K −34.4% 623K Feb 11, 2022
Q3 2021 Reduced −878K −$2.5M −48.0% 950K Nov 12, 2021
Q2 2021 Added +757K +$2.5M +70.7% 1.8M Aug 13, 2021
Q1 2021 First covered – – – 1.1M May 13, 2021
Data through Q1 2026 · filed May 14, 2026
21 grouped rows from 21 quarters

More Simons positions

United Therapeutics Corporation(UTHR)
$1.1B
1.7% of portfolio

Palantir Technologies Inc.(PLTR)
$997M
1.6% of portfolio

Apple Inc.(AAPL)
$778M
1.2% of portfolio

Kinross Gold Corporation(KGC)
$780M
1.2% of portfolio

Micron Technology, Inc.(MU)
$731M
1.1% of portfolio

VeriSign, Inc.(VRSN)
$700M
1.1% of portfolio

Common questions

Does Jim Simons own AKBA?

Yes. As of Q1 2026, Jim Simons disclosed 1.8M shares of AKBA, worth $2.5M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jim Simons buy AKBA?

Jim Simons held AKBA since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jim Simons sell AKBA?

The quarter-by-quarter table above shows each sale and reduction Jim Simons disclosed in AKBA. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of AKBA does Jim Simons own?

Jim Simons disclosed 1.8M shares of AKBA as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jim Simons pay for AKBA?

Jim Simons began building the AKBA position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.